CD24 and breast carcinoma: We then checked the expression of drug efflux transporters and breast cancer stem cell markers CD44+/CD24-, both of which are commonly considered to be key players in drug resistance; there were no differences in the expression of drug efflux transporters (Fig 2A) or CD44+/CD24- populations (Fig 2B–2D).